Monte Rosa Therapeutics, Inc. 10,638,476 Shares of Common Stock And Pre-Funded Warrants to Purchase 10,638,524 Shares of Common Stock Underwriting AgreementMonte Rosa Therapeutics, Inc. • May 16th, 2024 • Biological products, (no disgnostic substances) • New York
Company FiledMay 16th, 2024 Industry Jurisdiction